title: Re: Risk of fetal loss associated with invasive testing following combined first-trimester screening for Down syndrome: a national cohort of 147 987 singleton pregnancies. C. B. Wulff, T. A. Gerds, L. Rode, C. K. Ekelund, O. B. Petersen, A. Tabor and the Danish Fetal Medicine Study Group. Ultrasound Obstet Gynecol 2016; 47: 38-44.
authors.affiliation: Fetal Medicine Unit, Medway Maritime Hospital, Gillingham, Kent, UK. ranjit.akolekar@nhs.net.|Harris Birthright Research Centre, King's College Hospital, London, UK. ranjit.akolekar@nhs.net.
authors.forename: R
authors.initials: R
authors.lastname: Akolekar
mesh_terms: D004314:Down Syndrome / Q000000981:diagnostic imaging*; D006801:Humans; D011261:Pregnancy Trimester, First; D011266:Pregnancy-Associated Plasma Protein-A; D014463:Ultrasonography
chemical_list: D011266:Pregnancy-Associated Plasma Protein-A